Thiol-modified chitosan sulfate nanoparticles for protection and release of basic fibroblast growth factor

Bioconjugate Chemistry

Volumn 21, Issue 1, 2010, Pages 28-38

  Ho, Yi Cheng ^a   Wu, Shao Jung ^b   Mi, Fwu Long ^a   Chiu, Ya Lin ^c   Yu, Shu Huei ^a   Panda, Nilendu ^c   Sung, Hsing Wen ^c  

^a VANUNG UNIVERSITY   (Taiwan)

^b MING CHI UNIVERSITY OF TECHNOLOGY   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CHEMICAL ANALYSIS; CHITOSAN; FIBROBLASTS; POLYELECTROLYTES; SELF ASSEMBLY; SULFUR COMPOUNDS;

2-IMINOTHIOLANE; BASIC FIBROBLAST GROWTH FACTOR; CHITOSAN DERIVATIVES; CHITOSAN NANOPARTICLES; FIBROBLAST CULTURES; L929 FIBROBLASTS; MODIFIED CHITOSAN; O-CARBOXYMETHYL CHITOSANS; O-CARBOXYMETHYLCHITOSAN; SYNTHESISED;

NANOPARTICLES;

2 IMINOTHIOLANE; 4 THIO BUTYLAMIDINE; 6 O CARBOXYMETHYLCHITOSAN; AMIDINE; BASIC FIBROBLAST GROWTH FACTOR; CHITOSAN DERIVATIVE; NANOPARTICLE; THIOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; CROSS LINKING; CRYSTAL STRUCTURE; DRUG STRUCTURE; FIBROBLAST CULTURE; INFRARED SPECTROSCOPY; MITOGENESIS; MOUSE; NONHUMAN; PROTEIN SECRETION;

EID: 74949138688     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc900208t     Document Type: Article

References (40)

1. Burgess, W. H., and Maciag, T. (1989) The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58, 575-606.
2. Ruoslahti, E., and Yamaguchi, Y. (1991) Proteolglycans as modulators of growth factor activities. Cell 64, 867-869.
3. Gospodarowicz, D., Neufeld, G., and Schweigerer, L. (1986) Fibroblast growth factor. Mol. Cell. Endocrinol. 46, 187-204.
4. DiGabriele, A. D., Lax, I., Chen, D. I., Svahn, C. M., Jaye, M., Schlessinger, J., and Hendrickson, W. A. (1998) Structure of a heparin-linked biologically active dimer of fibroblast growth factor. Nature 393, 812-817.
5. Langer, R., and Vacanti, J. P. (1993) Tissue engineering. Science 260, 920-926.
6. Abrahma, J. A., Mergia, J., Whang, L., Tumolo, A., Friedman, J., Hjerrild, K. A., Gospodarowicz, D., and Fiddes, J. C. (1986) Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science 233, 545-548.
7. Schreiber, A. B., Kenney, J., Kowalski, J., Friesel, R., and Mehlman, T. (1985) Interaction of endothelial cell growth factor with heparin: characterization by receptor and antibody recognition. Proc. Natl. Acad. Sci. 82, 6138-6142.
8. Pike, D. B., Cai, S., Pomraning, K. R., Firpo, M. A., Fisher, R. J., Shu, X. Z., Prestwich, G. D., and Peattie, R. A. (2006) Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials 27, 5242-5251.
9. Chung, Y. I., Tae, G. , and Yuk, S. H. (2006) A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors. Biomaterials 27, 2621-2626.
10. Nillesen, S. T. M., Geutjes, P. J., Wismans, R., Schalkwijk, J., Daamen, W. F., and van Kuppevelt, T. H. (2007) Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials 28, 1123-1131.
11. Fisher, K. D., Ulbrich, K., Subr, V., Ward, C. M., Mautner, V., Blakey, D., and Seymour, L. W. (2000) A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression. Gene Ther. 7, 1337-1343.
12. Li, D., Yu, H., Huang, H., Shen, F., Wu, X., Li, J., Wang, J., Cao, X., Wang, Q., and Tang, G. (2007) FGF receptor-mediated gene delivery using ligands coupled to polyethylenimine. J. Biomater. Appl. 22, 163-180.
13. Baskaran, S., Grande, D., Sun, X. L., Yayon, A., and Chaikof, E. L. (2002) Glycosaminoglycan-mimetic biomaterials. 3. Glycopolymers prepared from alkene- derivatized mono- and disaccharide-based glycomonomers. Bioconjugate Chem. 13, 1309-1313.
14. Matsusaki, M., and Akashi, M. (2005) Novel functional biodegradable polymer IV: pH-sensitive controlled release of fibroblast growth factor-2 from a poly(γ-glutamic acid)-sulfonate matrix for tissue engineering. Biomacromolecules 6, 3351-3356.
15. Freeman, I., Kedem, A., and Cohen, S. (2008) The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. Biomaterials 29, 3260-3268.
16. Kim, T. H., Jiang, H. L., Jere, D., Park, I. K., Cho, M. H., Nah, J. W., Choi, Y. J., Akaike, T., and Cho, C. S. (2007) Chemical modification of chitosan as a gene carrier in vitro and in vivo. Prog. Polym. Sci. 32, 726-753.
17. Mi, F. L., Chen, C. T., Tseng, Y. C., Kuan, C. Y., and Shyu, S. S. (1997) Iron(III)- carboxymethylchitin microsphere for the pH-sensitive release of 6-mercaptopurine. J. Controlled Release 44, 19-32.
18. Holme, K. R., and Perlin, A. S. (1997) Chitosan N-sulfate. A water soluble polyelectrolyte. Carbohydr. Res. 302, 7-12.
19. Vikhoreva, G., Bannikova, G., Stolbushkina, P., Panov, A., Drozd, N., Makarov, V., Varlamov, V., and Gal'braikh, L. (2005) Preparation and anticoagulant activity of a low-molecular- weight sulfated chitosan. Carbohydr. Polym. 62, 327-332.
20. Huang, R, Du, Y., Yang, J., and Fan, L. (2003) Influence of functional groups on the in vitro anticoagulant activity of chitosan sulfate. Carbohydr. Res. 338, 483-489.
21. Matsusaki, M., Serizawa, T., Kishida, A., and Akashi, M. (2005) Novel functional biodegradable polymer II: bFGF stabilizing activity of poly(γ-glutamic acid) sulfonate. Biomacromolecules 6, 400-407.
22. Faham, S., Hileman, R. E., Fromm, J. R., Linhardt, R. J., and Rees, D. C. (1996) Heparin structure and interactions with basic fibroblast growth factor. Science 271, 1116-1120.
23. Bernkop-Schnurch, A., Guggi, D., and Pinter, Y. (2004) Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. J. Controlled Release 94, 177-186.
24. Masuko, T., Minami, A., Iwasaki, N., Majima, T., Nishimura, S., and Lee, Y. C. (2005) Thiolation of chitosan. Attachment of proteins via thioether formation. Biomacromolecules 6, 880-884.
25. Vanderhooft, J. L., Mann, B. K., and Prestwich, G. D. (2007) Synthesis and characterization of novel thiol-reactive poly(ethylene glycol) crosslinkers for biomaterials. Biomacromolecules 8, 2883-2889.
26. Mi, F. L., Wu, Y. Y., Lin, Y. H., Sonaje, K., Ho, Y. C., Chen, C. T., Juang, J. H., and Sung, H. W. (2008) Oral delivery of peptide drugs using nanoparticles self-assembled by poly(gamma-glutamic acid) and a chitosan derivative functionalized by trimethylation. Bioconjugate Chem. 19, 1248-1255.
27. Kommareddy, S., and Amiji, M. (2005) Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione. Bioconjugate Chem. 16, 1423-1432.
28. de Abreu, F. R., and Campana-Filho, S. P. (2009) Characteristics and properties of carboxymethylchitosan. Carbohydr. Polym. 75, 214-221.
29. Kajio, T., Kawahara, K., and Kato, K. (1992) Stabilization of basic fibroblast growth factor with dextran sulfate. FEBS 306, 243-246.
30. Kunou, M., and Hatanaka, K. (1995) Effects of heparin, dextran sulfate, and synthetic (1→6)-α-D-mannopyranan sulfate and acidic fibroblast growth factor on 3T3-L1 fibroblasts. Carbohydr. Res. 28, 107-112.
31. Rusnati, M., Coltrini, D., Caccia, P., Dell'Era, P., Zoppetti, G., Oreste, P., Valsasina, B., and Presta, M. (1994) Distinct role of 2-O-, N- and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1. Biochim. Biophys. Res. Commun. 203, 450-458.
32. Spivak-Kroitzman, T., Lemmon, M. A., Dikic, I., Ladbury, J. E., Pinchasi, D., Huang, J., Jaye, M., Crumley, G., Schlessinger, J., and Lax, I. (1994) Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 79, 1015-1024.
33. Kashyap, N., Viswanad, B., Sharma, G., Bhardwaj, V., Ramarao, P., Kumar, M. N. V., and Ravi. (2007) Design and evaluation of biodegradable, biosensitive in situ gelling system for pulsatile delivery of insulin. Biomaterials 28, 2051-2060.
34. Nobs, L., Buchegger, F., Gurny, R., and Alle?mann, E. (2006) Biodegradable nanoparticles for direct or two-step tumor immunotargeting. Bioconjugate Chem. 17, 139-145.
35. Dufresne, M. H., Gauthier, M. A., and Leroux, J. C. (2005) Thiol-functionalized polymeric micelles: from molecular recognition to improved mucoadhesion. Bioconjugate Chem. 16, 1027-1033.
36. Mi, F. L., Wu, Y. Y., Chiu, Y. L., Chen, M. C., Sung, H. W., Yu, S. H., Huang, M. F., and Shyu, S. S. (2007) Synthesis of a novel antennary type of galactosylated chitosan and preparation of its derived nanoparticles for targeting HepG2 cells. Biomacromolecules 8, 892-898.
37. Lee, P. W., Peng, S. F., Su, C. J., Mi, F. L., Chen, H. L., Wei, M. C., Lin, H. J., and Sung, H. W. (2008) The use of biodegradable polymeric nanoparticles in combination with a low-pressure gene gun for transdermal DNA delivery. Biomaterials 29, 742-751.
38. Lin, Y. H., Sonaje, K., Lin, K. M., Juang, J. H., Mi, F. L., Yang, H. W., and Sung, H. W. (2008) Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs. J. Controlled Rel. 132, 141-149.
39. Tabata, Y. (2005) Significance of release technology in tissue engineering. Drug Discovery Today 10, 1639-1646.
40. Biondi, M., Ungaro, F., Quaglia, F., and Netti, P. A. (2008) Controlled drug delivery in tissue engineering. Adv. Drug Delivery Rev. 60, 229-42.